IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Vaishali Pharma IPO is a Book Building IPO listing on NSE EMERGE exchange, with an ipo size of ₹ 14.23 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. Pantomath Capital Advisors is the merchant banker of Vaishali Pharma IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 23rd June 2017.
Vaishali Pharma IPO open date is 7th August 2017 and close date is 10th August 2017. IPO Allotment Date is 30th November -0001 and Listing date is 22nd August 2017.
IPO
Size:
₹ 14.23 Cr.
Avg IPO Size (Sector Based)
: ₹
21.99 cr.
Sector: Pharmaceutical
SME
IPO so far:
40
Merchant Banker:
Pantomath Capital
SME
IPO by BRLM so far:
104
City:
Mumbai
SME
IPO so far:
288
Revenue (annualised):
₹
67.11
cr. 
PE
Ratio:
72.00x
Average Sector PE Ratio: 20.74x
Vaishali Pharma IPO size is ₹ 14.23 Cr. with IPO price of ₹ 72.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Pantomath Capital Advisors Private Limited is the book-running lead manager of the Vaishali Pharma IPO. Bigshare Services Private Limited is the Registrar and Market Maker is Pantomath Stock Brokers Private Limited for Vaishali Pharma IPO.
Vaishali Pharma IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Vaishali Pharma IPO, based in Mumbai, operates in the Pharmaceutical sector with a focus on company dealing in pharmaceutical formulations. The company is launching its SME IPO on the NSE EMERGE exchange, using the Book Building Issue method. Vaishali Pharma IPO size is ₹ 14.23 Cr. with fresh issue size of ₹ 14 and Offer for sale being ₹ Nil
The IPO allotment date for Vaishali Pharma IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Vaishali Pharma IPO allotment status on the registrars website, Bigshare Services Private Limited . Vaishali Pharma IPO refund dates are 30th November -0001.
Vaishali Pharma IPO is expected to be listed on 22nd August 2017.
The upper price band for the Vaishali Pharma IPO is set at ₹ 72.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Vaishali Pharma IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Vaishali Pharma IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 10th August 2017. After submission, funds are blocked until the basis of allotment of Vaishali Pharma IPO is finalised.
The merchant banker for Vaishali Pharma IPO is Pantomath Capital Advisors Private Limited . Pantomath Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Vaishali Pharma IPO RHP for further details.
The registrar for Vaishali Pharma IPO is Bigshare Services Private Limited . Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Vaishali Pharma IPO through their official website or helpline.
Vaishali Pharma IPO was subscribed 0.00 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 14.23 Cr.
Avg IPO Size (Sector Based)
:
₹ 21.99 Cr.
Sector: Pharmaceutical
SME
IPO so far:
40
Merchant Banker:
Pantomath Capital
SME
IPO by BRLM so far:
104
City:
Mumbai
SME
IPO so far:
288
Revenue (annualised):
₹ 66.05 cr.
PE
Ratio:
72.00x
Average Sector PE Ratio: 20.74x
Vaishali Pharma IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Vaishali Pharma Financial Review Page
Merchant Banker(s) of Vaishali Pharma IPO: Pantomath Capital Advisors Private Limited
Vaishali Pharma IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Vaishali Pharma IPO listed at a listing price of 70.35 against the offer price of 72.00.
The current market price of Vaishali Pharma is 12.77.
Why Us?
